![]()
30.05.20132079
The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at increased risk of vascular disease.
![]()
29.05.20132008
Patients taking aspirin or warfarin (Coumadin) for prevention after a stroke don't need to stop the drug for dental procedures and probably can stay on it for most other minor medical procedures, the American Academy of Neurology recommended.
![]()
28.05.20131969
Rivaroxaban (Xarelto, Bayer ) has been approved in Europe for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction or stroke) following an acute coronary syndrome (ACS).
![]()
27.05.20132134
What is the predictive value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE])?
![]()
24.05.20131777
The risks of sports participation for implantable cardioverter-defibrillator (ICD) patients are unknown.
![]()
23.05.20132242
Hormonal therapy is part of an established treatment of gender identity disorder, however outcome data regarding mortality and morbidity are scant.
![]()
22.05.20131622
Chronic obstructive pulmonary disease (COPD) is a common and deadly disease.
